C. Iveson

VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION

D. Kerr, C. McConkey, J. Dunn, 2008 .

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

D. Kerr, C. McConkey, J. Dunn, 2007, The New England journal of medicine.

Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.

D. Kerr, C. McConkey, B. Warren, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.